Effects of scrubber discharges remain below environmental standards Existing environmental standards are not exceeded by the discharge of scrubber wastewater from sea-going vessels.
RIVM launches study on long-term effectiveness of COVID-19 vaccines RIVM is launching an extensive study today to research the long-term effectiveness of the various COVID-19 vaccines in the Netherlands.
Third wave shows major surge in hospital admissions in younger age groups In the week of 28 April to 4 May, there were 8% fewer new hospital admissions of people with COVID-19 compared to the week before.
First people with medical risk invited for vaccination People with a medical condition who are eligible for an annual seasonal flu vaccination will be invited for a COVID-19 vaccination in phases, starting on Thursday, 6 May.
People born in 1962 invited for COVID-19 vaccination The first people born in 1962 will be receiving an invitation for a COVID-19 vaccination this week. This group involves people who will be turning 59 this year.
Screening for chronic Q-fever is only cost-effective for specific groups RIVM has investigated for which groups screening for chronic Q-fever might be cost-effective.
Pneumococcal disease in the elderly The Health Council of the Netherlands is preparing an advice on pneumococcal vaccination for the elderly on request of the Ministry of Health, Welfare and Sport.
Statement on health care spending Down syndrome Recently a tweet containing a video from a Dutch tv-show about Down syndrome caused a lot of turmoil on Twitter.
Temporary dermal fillers prove harmless RIVM has conducted a market surveillance study of 26 so-called non-permanent fillers. All 26 products proved to be harmless.
Slight increase of the number of tuberculosis patients in 2016 For the second consecutive year, the number of tuberculosis (TB) patients in the Netherlands increased.